| |
Xconomy Exome Presents - New York Biotech
|
| With Michael Aberman (CEO, Quentis Therapeutics), Maria Gotsch (CEO, Partnership Fund for NYC), Marta Kerns (VP Biz Dev, Flatiron Health), Masoud Tavazoie (CEO, Rgenix), Bobby Green (SVP Clinical Oncology, Flatiron Health). |
| Riverpark at Alexandria Center for Life Science, 450 E 29th St |
|
Dec 18 (Tue) , 2018 @ 06:00 PM
| |
$50 |
|
|
|
|
|
|
|
|
| |
| DETAILS |
|
For the full list of speakers & event information, visitour event site.
If you can make it there, you can make it anywhere. Frank Sinatra may have written that line before dawn of the biotech industry, but it applies to New York City's long running aspirations to become a top life sciences hub. It's harder to build a successful life sciences company in New York City than in established hubs like Boston or San Francisco. The challenges-finding management talent, attracting funds, navigating a tough real estate market for affordable lab, office space, & housing-are well documented.
But that hasn't stopped people from going for it. Galvanized by local venture investors & a concerted government push, new startups are emerging that are committed to the Big Apple & aim to redefine the perception of New York biotech. Some homegrown companies have even become nationally known names, drawing the interest-and mega-dollars-of Big Pharma. Who are these companies, & how are they doing it? And what can others in the community learn from their stories?
Twitter:@Xconomy#nyxconbioSchedule:Registration & Networking: 5:00 - 6:00 pmProgram: 6:00 pm - 7:30 pmNetworking reception: 7:30 - 8:30 pmRegistration:Tickets are transferable but not refundable.To inquire about press registration, contact events@xconomy.com.
*Speakers & program schedule are subject to change.
Visit our event site for full event information.
|
|
|
|
|
|
|
|
